Budding of retroviruses utilizing divergent L domains requires nucleocapsid

Journal of Virology

Volumn 86, Issue 8, 2012, Pages 4182-4193

  Bello, Nana F ^a   Dussupt, Vincent ^a   Sette, Paola ^a   Rudd, Victoria ^a   Nagashima, Kunio ^b   Bibollet Ruche, Frederic ^c   Chen, Chaoping ^d   Montelaro, Ronald C ^e   Hahn, Beatrice H ^c   Bouamr, Fadila ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b SAIC FREDERICK INC   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d Department of Environmental and Radiological Health Sciences   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESCRT PROTEIN; GAG PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; ENDOCYTOSIS; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; RETROVIRUS; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS MUTANT; VIRUS NUCLEOCAPSID; VIRUS RELEASE;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; CELL LINE; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; GENE PRODUCTS, GAG; HUMANS; INFECTIOUS ANEMIA VIRUS, EQUINE; MOLECULAR SEQUENCE DATA; MUTATION; NUCLEOCAPSID; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RETROVIRIDAE; SEQUENCE ALIGNMENT; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS RELEASE;

EQUINE INFECTIOUS ANEMIA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 84861393911     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.07105-11     Document Type: Article

References (80)

1. Aldovini A, Young RA. 1990. Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus. J. Virol. 64:1920-1926.
2. Amarasinghe GK, et al. 2000. NMR structure of the HIV-1 nucleocapsid protein bound to stem-loop SL2 of the psi-RNA packaging signal. Implications for genome recognition. J. Mol. Biol. 301:491-511.
3. Amodeo P, Castiglione Morelli MA, Ostuni A, Battistuzzi G, Bavoso A. 2006. Structural features in EIAV NCp11: a lentivirus nucleocapsid protein with a short linker. Biochemistry 45:5517-5526.
4. Babst M, Katzmann DJ, Estepa-Sabal EJ, Meerloo T, Emr SD. 2002. Escrt-III: an endosome-associated heterooligomeric protein complex required for mvb sorting. Dev. Cell 3:271-282.
5. Babst M, Sato TK, Banta LM, Emr SD. 1997. Endosomal transport function in yeast requires a novel AAA-type ATPase, Vps4p. EMBO J. 16:1820-1831.
6. Babst M, Wendland B, Estepa EJ, Emr SD. 1998. The Vps4p AAA ATPase regulates membrane association of a Vps protein complex required for normal endosome function. EMBO J. 17:2982-2993.
7. Bello NF, et al. 2011. Distal leucines are key functional determinants of Alix-binding SIVsmE543 and SIVmac239 type 3 L domains. J. Virol. 85: 11532-11537.
8. Berkowitz RD, Luban J, Goff SP. 1993. Specific binding of human immunodeficiency virus type 1 gag polyprotein and nucleocapsid protein to viral RNAs detected by RNA mobility shift assays. J. Virol. 67:7190-7200.
9. Bibollet-Ruche F, et al. 2004. Complete genome analysis of one of the earliest SIVcpzPtt strains from Gabon (SIVcpzGAB2). AIDS Res. Hum. Retroviruses 20:1377-1381.
10. Bieniasz PD. 2009. The cell biology of HIV-1 virion genesis. Cell Host Microbe 5:550-558.
11. Bryant M, Ratner L. 1990. Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proc. Natl. Acad. Sci. U. S. A. 87:523-527.
12. Burniston MT, Cimarelli A, Colgan J, Curtis SP, Luban J. 1999. Human immunodeficiency virus type 1 Gag polyprotein multimerization requires the nucleocapsid domain and RNA and is promoted by the capsid-dimer interface and the basic region of matrix protein. J. Virol. 73:8527-8540.
13. Campbell S, Rein A. 1999. In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain. J. Virol. 73:2270-2279.14.
14. Campbell S, Vogt VM. 1995. Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1. J. Virol. 69:6487-6497.
15. Carter CA. 2002. Tsg101: HIV-1's ticket to ride. Trends Microbiol. 10: 203-205.
16. Chatel-Chaix L, Boulay K, Mouland AJ, Desgroseillers L. 2008. The host protein Staufen1 interacts with the Pr55Gag zinc fingers and regulates HIV-1 assembly via its N-terminus. Retrovirology 5:41.
17. Cimarelli A, Sandin S, Hoglund S, Luban J. 2000. Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA. J. Virol. 74:3046-3057.
18. Cook RF, et al. 1998. Development and characterization of an in vivo pathogenic molecular clone of equine infectious anemia virus. J. Virol. 72:1383-1393.
19. Darlix JL, et al. 2011. Flexible nature and specific functions of the HIV-1 nucleocapsid protein. J. Mol. Biol. 410:565-581.
20. De Guzman RN, et al. 1998. Structure of the HIV-1 nucleocapsid protein bound to the SL3 psi-RNA recognition element. Science 279:384-388.
21. Demirov DG, Freed EO. 2004. Retrovirus budding. Virus Res. 106:87-102.
22. Demirov DG, Ono A, Orenstein JM, Freed EO. 2002. Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function. Proc. Natl. Acad. Sci. U. S. A. 99:955-960.
23. De Rocquigny H, et al. 1992. Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers. Proc. Natl. Acad. Sci. U. S. A. 89:6472-6476.
24. Dilley KA, Gregory D, Johnson MC, Vogt VM. 2010. An LYPSL late domain in the gag protein contributes to the efficient release and replication of Rous sarcoma virus. J. Virol. 84:6276-6287.
25. Dooher JE, Schneider BL, Reed JC, Lingappa JR. 2007. Host ABCE1 is at plasma membrane HIV assembly sites and its dissociation from Gag is linked to subsequent events of virus production. Traffic 8:195-211.
26. nL late domains to recruit the cellular machinery necessary for viral budding. PLoS Pathog. 5:e1000339.
27. Dussupt V, et al. 2011. Basic residues in the nucleocapsid domain of Gag are critical for late events of HIV-1 budding. J. Virol. 85:2304-2315.
28. Ehrlich LS, Agresta BE, Carter CA. 1992. Assembly of recombinant human immunodeficiency virus type 1 capsid protein in vitro. J. Virol. 66:4874-4883.
29. Engeland CE, et al. 2011. The cellular protein Lyric interacts with HIV-1 Gag. J. Virol. 85:13322-13332.
30. Fisher RD, et al. 2007. Structural and biochemical studies of ALIX/AIP1 and its role in retrovirus budding. Cell 128:841-852.
31. Gamble TR, et al. 1997. Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science 278:849-853.
32. Garrus JE, et al. 2001. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107:55-65.
33. Göttlinger HG, Dorfman T, Sodroski JG, Haseltine WA. 1991. Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc. Natl. Acad. Sci. U. S. A. 88:3195-3199.
34. Göttlinger HG, Sodroski JG, Haseltine WA. 1989. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U. S. A. 86:5781-5785.
35. Gross I, Hohenberg H, Huckhagel C, Kräusslich HG. 1998. N-terminal extension of human immunodeficiency virus capsid protein converts the in vitro assembly phenotype from tubular to spherical particles. J. Virol. 72:4798-4810.
36. Hirsch V, et al. 1997. A molecularly cloned, pathogenic, neutralizationresistant simian immunodeficiency virus, SIVsmE543-3. J. Virol. 71: 1608-1620.
37. Hogue IB, Hoppe A, Ono A. 2009. Quantitative fluorescence resonance energy transfer microscopy analysis of the human immunodeficiency virus type 1 Gag-Gag interaction: relative contributions of the CA and NC domains and membrane binding. J. Virol. 83:7322-7336.
38. Houzet L, et al. 2008. Nucleocapsid mutations turn HIV-1 into a DNAcontaining virus. Nucleic Acids Res. 36:2311-2319.
39. Huang M, Orenstein JM, Martin MA, Freed EO. 1995. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J. Virol. 69:6810-6818.
40. Jouvenet N, Zhadina M, Bieniasz PD, Simon SM. 2011. Dynamics of ESCRT protein recruitment during retroviral assembly. Nat. Cell Biol. 13:394-401.
41. Katoh K, et al. 2003. The ALG-2-interacting protein Alix associates with CHMP4b, a human homologue of yeast Snf7 that is involved in multivesicular body sorting. J. Biol. Chem. 278:39104-39113.
42. Kikonyogo A, et al. 2001. Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for gag budding from cells. Proc. Natl. Acad. Sci. U. S. A. 98:11199-11204.
43. Kim J, et al. 2005. Structural basis for endosomal targeting by the Bro1 domain. Dev. Cell 8:937-947.
44. Levin JG, Mitra M, Mascarenhas A, Musier-Forsyth K. 2010. Role of HIV-1 nucleocapsid protein in HIV-1 reverse transcription. RNA Biol. 7:754-774.
45. Li F, Chen C, Puffer BA, Montelaro RC. 2002. Functional replacement and positional dependence of homologous and heterologous L domains in equine infectious anemia virus replication. J. Virol. 76:1569-1577.
46. Li H, Dou J, Ding L, Spearman P. 2007. Myristoylation is required for human immunodeficiency virus type 1 Gag-Gag multimerization in mammalian cells. J. Virol. 81:12899-12910.
47. Llewellyn GN, Hogue IB, Grover JR, Ono A. 2010. Nucleocapsid promotes localization of HIV-1 gag to uropods that participate in virological synapses between T cells. PLoS Pathog. 6:e1001167.
48. Martin-Serrano J, Bieniasz PD. 2003. A bipartite late-budding domain in human immunodeficiency virus type 1. J. Virol. 77:12373-12377.
49. Martin-Serrano J, Eastman SW, Chung W, Bieniasz PD. 2005. HECT ubiquitin ligases link viral and cellular PPXY motifs to the vacuolar protein-sorting pathway. J. Cell Biol. 168:89-101.
50. Martin-Serrano J, Perez-Caballero D, Bieniasz PD. 2004. Context-dependent effects of L domains and ubiquitination on viral budding. J. Virol. 78:5554-5563.
51. Martin-Serrano J, Yarovoy A, Perez-Caballero D, Bieniasz PD. 2003. Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by using alternative adaptor proteins. Proc. Natl. Acad. Sci. U. S. A. 100:12414-12419.
52. Martin-Serrano J, Zang T, Bieniasz PD. 2001. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat. Med. 7:1313-1319.
53. McCullough J, Fisher RD, Whitby FG, Sundquist WI, Hill CP. 2008. ALIX-CHMP4 interactions in the human ESCRT pathway. Proc. Natl. Acad. Sci. U. S. A. 105:7687-7691.
54. Mirambeau G, Lyonnais S, Gorelick RJ. 2010. Features, processing states, and heterologous protein interactions in the modulation of the retroviral nucleocapsid protein function. RNA Biol. 7:724-734.
55. Montelaro RC, Parekh B, Orrego A, Issel CJ. 1984. Antigenic variation during persistent infection by equine infectious anemia virus, a retrovirus. J. Biol. Chem. 259:10539-10544.
56. Morita E, et al. 2011. ESCRT-III protein requirements for HIV-1 budding. Cell Host Microbe 9:235-242.
57. Morita E, Sundquist WI. 2004. Retrovirus budding. Annu. Rev. Cell Dev. Biol. 20:395-425.
58. Muriaux D, Darlix JL. 2010. Properties and functions of the nucleocapsid protein in virus assembly. RNA Biol. 7:744-753.
59. Ono A, Ablan SD, Lockett SJ, Nagashima K, Freed EO. 2004. Phosphatidylinositol(4,5)bisphosphate regulates HIV-1 Gag targeting to the plasma membrane. Proc. Natl. Acad. Sci. U. S. A. 101:14889-14894.
60. Ott DE, et al. 2003. Elimination of protease activity restores efficient virion production to a human immunodeficiency virus type 1 nucleocapsid deletion mutant. J. Virol. 77:5547-5556.
61. Pires R, et al. 2009. A crescent-shaped ALIX dimer targets ESCRT-III CHMP4 filaments. Structure 17:843-856.
62. Popov S, Popova E, Inoue M, Göttlinger HG. 2008. Human immunodeficiency virus type 1 Gag engages the Bro1 domain of ALIX/AIP1 through the nucleocapsid. J. Virol. 82:1389-1398.
63. Popova E, Popov S, Göttlinger HG. 2010. Human immunodeficiency virus type 1 nucleocapsid-p1 confers ESCRT pathway dependence. J. Virol. 84:6590-6597.
64. Pornillos O, et al. 2009. X-ray structures of the hexameric building block of the HIV capsid. Cell 137:1282-1292.
65. Puffer BA, Parent LJ, Wills JW, Montelaro RC. 1997. Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein. J. Virol. 71:6541-6546.
66. nL L domain motif. J. Virol. 84:8181-8192.
67. Sette P, et al. 2011. The Phe105 loop of Alix Bro1 domain plays a key role in HIV-1 release. Structure 19:1485-1495.
68. Strack B, Calistri A, Craig S, Popova E, Göttlinger HG. 2003. AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell 114:689-699.
69. Strack B, Calistri A, Göttlinger HG. 2002. Late assembly domain function can exhibit context dependence and involves ubiquitin residues implicated in endocytosis. J. Virol. 76:5472-5479.
70. Stuchell-Brereton MD, et al. 2007. ESCRT-III recognition by VPS4 ATPases. Nature 449:740-744.
71. Thomas JA, Bosche WJ, Shatzer TL, Johnson DG, Gorelick RJ. 2008. Mutations in human immunodeficiency virus type 1 nucleocapsid protein zinc fingers cause premature reverse transcription. J. Virol. 82:9318-9328.
72. Usami Y, Popov S, Göttlinger HG. 2007. Potent rescue of human immunodeficiency virus type 1 late domain mutants by ALIX/AIP1 depends on its CHMP4 binding site. J. Virol. 81:6614-6622.
73. VerPlank L, et al. 2001. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag). Proc. Natl. Acad. Sci. U. S. A. 98:7724-7729.
74. von Schwedler UK, et al. 2003. The protein network of HIV budding. Cell 114:701-713.
75. Wang SW, Aldovini A. 2002. RNA incorporation is critical for retroviral particle integrity after cell membrane assembly of Gag complexes. J. Virol. 76:11853-11865.
76. Yuan B, Campbell S, Bacharach E, Rein A, Goff SP. 2000. Infectivity of Moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retroviruses. J. Virol. 74:7250-7260.
77. Zhai Q, et al. 2008. Structural and functional studies of ALIX interactions with YPX(n)L late domains of HIV-1 and EIAV. Nat. Struct. Mol. Biol. 15:43-49.
78. Zhai Q, Landesman MB, Robinson H, Sundquist WI, Hill CP. 2011. Identification and structural characterization of the ALIX-binding late domains of simian immunodeficiency virus SIVmac239 and SIVagmTan-1. J. Virol. 85:632-637.
79. Zhou W, Parent LJ, Wills JW, Resh MD. 1994. Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J. Virol. 68:2556-2569.
80. Zimmerman C, et al. 2002. Identification of a host protein essential for assembly of immature HIV-1 capsids. Nature 415:88-92.